三叉神经痛非等中心放射外科治疗计划中的脑干剂量约束:单中心经验
单中心回顾性分析66例接受射波刀立体定向放射外科治疗的三叉神经痛患者,比较标准剂量期(n=38)与降低剂量期(n=28)的结局,两组处方剂量均为60 Gy,脑干最大剂量分别允许45 Gy和25 Gy。结果显示降低脑干最大剂量可提供良好疼痛控制且不影响面部麻木,较长三叉神经可能获得更好长期结局。
要点
- 降低脑干最大剂量至25 Gy仍可获良好疼痛控制且不增加面部麻木。
- 标准剂量组疼痛控制改善至23.4%,降低剂量组改善至8.3%(均P<0.001)。
- 回归分析提示降低脑干暴露(P=0.01)和较长三叉神经(P=0.01)预测持久疼痛控制。
核心结论
- 降低脑干最大剂量可提供良好疼痛控制且不影响面部麻木,较长神经可能获得更好长期结局并有助于优化个体化计划。
研究设计与样本
- 回顾性单中心研究,纳入66例接受射波刀立体定向放射外科治疗的三叉神经痛患者,比较标准剂量期(n=38)与降低剂量期(n=28)的结局。
主要发现
- 匹配后标准剂量组和降低剂量组中位随访分别为25个月和19.5个月。
- 标准剂量组和降低剂量组平均三叉神经长度分别为8.55 mm和9.46 mm。
- 标准剂量组和降低剂量组基线疼痛控制不佳率分别为97%和88%,分别改善至23.4%和8.3%(均P<0.001)。
- 标准剂量组和降低剂量组基线令人困扰的麻木率均为零,分别增加至25%(P=0.006)和21%(P=0.07)。
- 回归分析提示降低脑干暴露(P=0.01)以及较长三叉神经(P=0.01)可预测持久疼痛控制。
关键数值与推荐
- 标准剂量和降低剂量均允许脑干最大剂量分别为45 Gy和25 Gy,处方剂量均为60 Gy。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: CyberKnife stereotactic radiosurgery (SRS) for trigeminal neuralgia (TGN) administers nonisometric, conformational high-dose radiation to the trigeminal nerve with risk of subsequent hypoesthesia. METHODS: We performed a retrospective, single-institution review of 66 patients with TGN treated with CyberKnife SRS to compare outcomes from 2 distinct treatment periods: standard dosing (n = 38) and reduced dosing (n = 28). Standard and reduced dosing permitted a maximum brainstem dose of 45 Gy and 25 Gy, respectively, each with a prescription dose of 60 Gy. Primary and secondary outcomes were Barrow Neurologic Institute pain and numbness scores. Maximum brainstem dose, prepontine nerve length, and treatment history were recorded for their predictive contributions by logistic regression. RESULTS: After matching, patients in the standard dosing and reduced dosing groups were followed for a median of 25 months and 19.5 months, respectively. Mean trigeminal nerve length was 8.55 mm in the standard dosing group and 9.46 mm in the reduced dosing group. Baseline rates of poorly controlled pain were 97% and 88%, respectively, which improved to 23.4% and 8.3%, respectively (P < 0.001 for both). The baseline rates of bothersome numbness were null in both groups, and increased to 25% in the standard group (P = 0.006) and to 21% in the reduced group (P = 0.07). Regression analyses suggested that reduced brainstem exposure (P = 0.01), as well as a longer trigeminal nerve (P = 0.01), were predictive of durable pain control. CONCLUSIONS: These outcomes demonstrate that a lower maximum brainstem dose can provide excellent pain control without affecting facial numbness. Longer nerves may achieve better long-term outcomes and help optimize individual plans.
引用
- Zhang M, Lamsam LA, Schoen MK, et al. Brainstem Dose Constraints in Nonisometric Radiosurgical Treatment Planning of Trigeminal Neuralgia: A Single-Institution Experience. World Neurosurg. 2018. PMID: 29454124. doi:10.1016/j.wneu.2018.02.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。